Evidence map›Paper›PMID 26389800›Full record

ArticlePloS one2015

A Versatile Simple Capture Assay for Assessing the Structural Integrity of MHC Multimer Reagents.

Brendan K Reed, Laura B Chopp, Courtney S Malo, Danielle N Renner, Virginia S Van Keulen, Megan A Girtman, Wendy N Nevala, Kevin D Pavelko, Diana Gil, Adam G Schrum and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2DFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Brendan K ReedDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Laura B ChoppDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Courtney S MaloDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Danielle N RennerDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Virginia S Van KeulenDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Megan A GirtmanDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Wendy N NevalaDepartment of Medicine, Division of Hematology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Kevin D PavelkoDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Diana GilDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Adam G SchrumDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Aaron J JohnsonDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Larry R PeaseDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, United States of America.
Mayo Clinic in Arizona · USMayo Clinic · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
PHD TRAINING PROGRAM IN BASIC IMMUNOLOGYT32AI007425 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 1995 to 2020
$3.6M
Altered MHC ligand vaccine designR21AI097337 · NIAID · MAYO CLINIC ROCHESTER · PI PEASE, LARRY R · 2013 to 2014
$423k
NCI NIH HHS P30 CA015083NIAID NIH HHS R21 AI097337NIAID NIH HHS R21 AI097337-01A1NIAID NIH HHS T32 AI007425NIAID NIH HHS T32 AI07425
6 · The paper itself

Abstract

Antigen-specific T cell responses can be visualized using MHC:peptide multimers. In cases where robust T cell controls are not readily available to assess the integrity of multimer reagents prior to analyzing limited sample, the ability to assess the structural integrity of MHC multimers before their use in critical experiments would be useful. We present a method to probe the structural integrity of MHC multimers using antibodies specific for conformational determinants. Beads coated with anti-mouse Ig are incubated with conformation-specific mouse monoclonal antibody and then with fluorescently tagged MHC multimer. The ability of the bead to capture the labeled multimer can be measured semi-quantitatively by flow cytometry. In this manner, the correct folding of MHC multimers can be visualized and batches of multimer can be compared for quality control. Because there are multiple conformational epitopes formed by various molecular interactions among heavy chain, peptide, and β2M, this capture assay can assess the fidelity of each aspect of multimer structure, depending on the availability of antibodies. The described approach could be particularly useful for studies using irreplaceable samples, including patient samples collected in clinical trials.

Indexed as

AnimalsAntigensMiceProtein ConformationT-LymphocytesAntigens

Identifiers

PMID26389800
PMCPMC4577079
OpenAlexW2298519042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.